Part 1
Part 2
Part 3
Part 5
Description
Adapalene is a third generation retinoid used primarily to treat mild to moderate acne, but is also used to treat Keratosis Pilaris and other skin conditions. The global market for Adapalene was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Adapalene was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Adapalene was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Adapalene was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Adapalene include Galderma, Glenmark Pharmaceuticals, Fougera Pharmaceuticals, A-S Medication Solutions, Taro Pharmaceuticals, Sandoz Inc., Prasco Laboratories, Actavis Pharma Company and Perrigo, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Adapalene, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Adapalene by region & country, by Type, and by Application.
The Adapalene market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adapalene.
Market Segmentation
Report Metric
Details
Report Title
Adapalene - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Adapalene Companies Covered
Galderma, Glenmark Pharmaceuticals, Fougera Pharmaceuticals, A-S Medication Solutions, Taro Pharmaceuticals, Sandoz Inc., Prasco Laboratories, Actavis Pharma Company, Perrigo, Physicians Total Care, DPT Laboratories, Tianjin Jinyao Pharmaceutical, Heilongjiang fuhe Pharmaceutical Group, Sichuan Mingxin Pharmaceutical, Hainan Quanxing Pharmaceutical, Jiangsu Zhongdan Pharmaceutical, Jiangsu Fubang Pharmaceutical
Global Adapalene Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Adapalene Market, Segment by Type
Cream
Gel
Lotion
Global Adapalene Market, Segment by Application
Hospital
Compounding Pharmacy
Skin Clinic
Beauty Center
Brick-and-mortar Pharmacy
Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Adapalene manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Adapalene in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Adapalene in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Adapalene Product Introduction
1.2 Global Adapalene Market Size Forecast
1.3 Adapalene Market Trends & Drivers
1.3.1 Adapalene Industry Trends
1.3.2 Adapalene Market Drivers & Opportunity
1.3.3 Adapalene Market Challenges
1.3.4 Adapalene Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Adapalene Players Revenue Ranking (2023)
2.2 Global Adapalene Revenue by Company (2019-2024)
2.3 Key Companies Adapalene Manufacturing Base Distribution and Headquarters
2.4 Key Companies Adapalene Product Offered
2.5 Key Companies Time to Begin Mass Production of Adapalene
2.6 Adapalene Market Competitive Analysis
2.6.1 Adapalene Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Adapalene Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adapalene as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Cream
3.1.2 Gel
3.1.3 Lotion
3.2 Global Adapalene Sales Value by Type
3.2.1 Global Adapalene Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Adapalene Sales Value, by Type (2019-2030)
3.2.3 Global Adapalene Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Compounding Pharmacy
4.1.3 Skin Clinic
4.1.4 Beauty Center
4.1.5 Brick-and-mortar Pharmacy
4.1.6 Other
4.2 Global Adapalene Sales Value by Application
4.2.1 Global Adapalene Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Adapalene Sales Value, by Application (2019-2030)
4.2.3 Global Adapalene Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Adapalene Sales Value by Region
5.1.1 Global Adapalene Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Adapalene Sales Value by Region (2019-2024)
5.1.3 Global Adapalene Sales Value by Region (2025-2030)
5.1.4 Global Adapalene Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Adapalene Sales Value, 2019-2030
5.2.2 North America Adapalene Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Adapalene Sales Value, 2019-2030
5.3.2 Europe Adapalene Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Adapalene Sales Value, 2019-2030
5.4.2 Asia Pacific Adapalene Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Adapalene Sales Value, 2019-2030
5.5.2 South America Adapalene Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Adapalene Sales Value, 2019-2030
5.6.2 Middle East & Africa Adapalene Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Adapalene Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Adapalene Sales Value
6.3 United States
6.3.1 United States Adapalene Sales Value, 2019-2030
6.3.2 United States Adapalene Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Adapalene Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Adapalene Sales Value, 2019-2030
6.4.2 Europe Adapalene Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Adapalene Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Adapalene Sales Value, 2019-2030
6.5.2 China Adapalene Sales Value by Type (%), 2023 VS 2030
6.5.3 China Adapalene Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Adapalene Sales Value, 2019-2030
6.6.2 Japan Adapalene Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Adapalene Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Adapalene Sales Value, 2019-2030
6.7.2 South Korea Adapalene Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Adapalene Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Adapalene Sales Value, 2019-2030
6.8.2 Southeast Asia Adapalene Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Adapalene Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Adapalene Sales Value, 2019-2030
6.9.2 India Adapalene Sales Value by Type (%), 2023 VS 2030
6.9.3 India Adapalene Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Galderma
7.1.1 Galderma Profile
7.1.2 Galderma Main Business
7.1.3 Galderma Adapalene Products, Services and Solutions
7.1.4 Galderma Adapalene Revenue (US$ Million) & (2019-2024)
7.1.5 Galderma Recent Developments
7.2 Glenmark Pharmaceuticals
7.2.1 Glenmark Pharmaceuticals Profile
7.2.2 Glenmark Pharmaceuticals Main Business
7.2.3 Glenmark Pharmaceuticals Adapalene Products, Services and Solutions
7.2.4 Glenmark Pharmaceuticals Adapalene Revenue (US$ Million) & (2019-2024)
7.2.5 Glenmark Pharmaceuticals Recent Developments
7.3 Fougera Pharmaceuticals
7.3.1 Fougera Pharmaceuticals Profile
7.3.2 Fougera Pharmaceuticals Main Business
7.3.3 Fougera Pharmaceuticals Adapalene Products, Services and Solutions
7.3.4 Fougera Pharmaceuticals Adapalene Revenue (US$ Million) & (2019-2024)
7.3.5 A-S Medication Solutions Recent Developments
7.4 A-S Medication Solutions
7.4.1 A-S Medication Solutions Profile
7.4.2 A-S Medication Solutions Main Business
7.4.3 A-S Medication Solutions Adapalene Products, Services and Solutions
7.4.4 A-S Medication Solutions Adapalene Revenue (US$ Million) & (2019-2024)
7.4.5 A-S Medication Solutions Recent Developments
7.5 Taro Pharmaceuticals
7.5.1 Taro Pharmaceuticals Profile
7.5.2 Taro Pharmaceuticals Main Business
7.5.3 Taro Pharmaceuticals Adapalene Products, Services and Solutions
7.5.4 Taro Pharmaceuticals Adapalene Revenue (US$ Million) & (2019-2024)
7.5.5 Taro Pharmaceuticals Recent Developments
7.6 Sandoz Inc.
7.6.1 Sandoz Inc. Profile
7.6.2 Sandoz Inc. Main Business
7.6.3 Sandoz Inc. Adapalene Products, Services and Solutions
7.6.4 Sandoz Inc. Adapalene Revenue (US$ Million) & (2019-2024)
7.6.5 Sandoz Inc. Recent Developments
7.7 Prasco Laboratories
7.7.1 Prasco Laboratories Profile
7.7.2 Prasco Laboratories Main Business
7.7.3 Prasco Laboratories Adapalene Products, Services and Solutions
7.7.4 Prasco Laboratories Adapalene Revenue (US$ Million) & (2019-2024)
7.7.5 Prasco Laboratories Recent Developments
7.8 Actavis Pharma Company
7.8.1 Actavis Pharma Company Profile
7.8.2 Actavis Pharma Company Main Business
7.8.3 Actavis Pharma Company Adapalene Products, Services and Solutions
7.8.4 Actavis Pharma Company Adapalene Revenue (US$ Million) & (2019-2024)
7.8.5 Actavis Pharma Company Recent Developments
7.9 Perrigo
7.9.1 Perrigo Profile
7.9.2 Perrigo Main Business
7.9.3 Perrigo Adapalene Products, Services and Solutions
7.9.4 Perrigo Adapalene Revenue (US$ Million) & (2019-2024)
7.9.5 Perrigo Recent Developments
7.10 Physicians Total Care
7.10.1 Physicians Total Care Profile
7.10.2 Physicians Total Care Main Business
7.10.3 Physicians Total Care Adapalene Products, Services and Solutions
7.10.4 Physicians Total Care Adapalene Revenue (US$ Million) & (2019-2024)
7.10.5 Physicians Total Care Recent Developments
7.11 DPT Laboratories
7.11.1 DPT Laboratories Profile
7.11.2 DPT Laboratories Main Business
7.11.3 DPT Laboratories Adapalene Products, Services and Solutions
7.11.4 DPT Laboratories Adapalene Revenue (US$ Million) & (2019-2024)
7.11.5 DPT Laboratories Recent Developments
7.12 Tianjin Jinyao Pharmaceutical
7.12.1 Tianjin Jinyao Pharmaceutical Profile
7.12.2 Tianjin Jinyao Pharmaceutical Main Business
7.12.3 Tianjin Jinyao Pharmaceutical Adapalene Products, Services and Solutions
7.12.4 Tianjin Jinyao Pharmaceutical Adapalene Revenue (US$ Million) & (2019-2024)
7.12.5 Tianjin Jinyao Pharmaceutical Recent Developments
7.13 Heilongjiang fuhe Pharmaceutical Group
7.13.1 Heilongjiang fuhe Pharmaceutical Group Profile
7.13.2 Heilongjiang fuhe Pharmaceutical Group Main Business
7.13.3 Heilongjiang fuhe Pharmaceutical Group Adapalene Products, Services and Solutions
7.13.4 Heilongjiang fuhe Pharmaceutical Group Adapalene Revenue (US$ Million) & (2019-2024)
7.13.5 Heilongjiang fuhe Pharmaceutical Group Recent Developments
7.14 Sichuan Mingxin Pharmaceutical
7.14.1 Sichuan Mingxin Pharmaceutical Profile
7.14.2 Sichuan Mingxin Pharmaceutical Main Business
7.14.3 Sichuan Mingxin Pharmaceutical Adapalene Products, Services and Solutions
7.14.4 Sichuan Mingxin Pharmaceutical Adapalene Revenue (US$ Million) & (2019-2024)
7.14.5 Sichuan Mingxin Pharmaceutical Recent Developments
7.15 Hainan Quanxing Pharmaceutical
7.15.1 Hainan Quanxing Pharmaceutical Profile
7.15.2 Hainan Quanxing Pharmaceutical Main Business
7.15.3 Hainan Quanxing Pharmaceutical Adapalene Products, Services and Solutions
7.15.4 Hainan Quanxing Pharmaceutical Adapalene Revenue (US$ Million) & (2019-2024)
7.15.5 Hainan Quanxing Pharmaceutical Recent Developments
7.16 Jiangsu Zhongdan Pharmaceutical
7.16.1 Jiangsu Zhongdan Pharmaceutical Profile
7.16.2 Jiangsu Zhongdan Pharmaceutical Main Business
7.16.3 Jiangsu Zhongdan Pharmaceutical Adapalene Products, Services and Solutions
7.16.4 Jiangsu Zhongdan Pharmaceutical Adapalene Revenue (US$ Million) & (2019-2024)
7.16.5 Jiangsu Zhongdan Pharmaceutical Recent Developments
7.17 Jiangsu Fubang Pharmaceutical
7.17.1 Jiangsu Fubang Pharmaceutical Profile
7.17.2 Jiangsu Fubang Pharmaceutical Main Business
7.17.3 Jiangsu Fubang Pharmaceutical Adapalene Products, Services and Solutions
7.17.4 Jiangsu Fubang Pharmaceutical Adapalene Revenue (US$ Million) & (2019-2024)
7.17.5 Jiangsu Fubang Pharmaceutical Recent Developments
8 Industry Chain Analysis
8.1 Adapalene Industrial Chain
8.2 Adapalene Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Adapalene Sales Model
8.5.2 Sales Channel
8.5.3 Adapalene Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Adapalene Market Trends
Table 2. Adapalene Market Drivers & Opportunity
Table 3. Adapalene Market Challenges
Table 4. Adapalene Market Restraints
Table 5. Global Adapalene Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Adapalene Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Adapalene Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Adapalene Product Type
Table 9. Key Companies Time to Begin Mass Production of Adapalene
Table 10. Global Adapalene Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adapalene as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Adapalene Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Adapalene Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Adapalene Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Adapalene Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Adapalene Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Adapalene Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Adapalene Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Adapalene Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Adapalene Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Adapalene Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Adapalene Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Adapalene Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Adapalene Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Adapalene Sales Value by Region (2019-2024) & (%)
Table 27. Global Adapalene Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Adapalene Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Adapalene Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Adapalene Sales Value, (2025-2030) & (US$ Million)
Table 31. Galderma Basic Information List
Table 32. Galderma Description and Business Overview
Table 33. Galderma Adapalene Products, Services and Solutions
Table 34. Revenue (US$ Million) in Adapalene Business of Galderma (2019-2024)
Table 35. Galderma Recent Developments
Table 36. Glenmark Pharmaceuticals Basic Information List
Table 37. Glenmark Pharmaceuticals Description and Business Overview
Table 38. Glenmark Pharmaceuticals Adapalene Products, Services and Solutions
Table 39. Revenue (US$ Million) in Adapalene Business of Glenmark Pharmaceuticals (2019-2024)
Table 40. Glenmark Pharmaceuticals Recent Developments
Table 41. Fougera Pharmaceuticals Basic Information List
Table 42. Fougera Pharmaceuticals Description and Business Overview
Table 43. Fougera Pharmaceuticals Adapalene Products, Services and Solutions
Table 44. Revenue (US$ Million) in Adapalene Business of Fougera Pharmaceuticals (2019-2024)
Table 45. Fougera Pharmaceuticals Recent Developments
Table 46. A-S Medication Solutions Basic Information List
Table 47. A-S Medication Solutions Description and Business Overview
Table 48. A-S Medication Solutions Adapalene Products, Services and Solutions
Table 49. Revenue (US$ Million) in Adapalene Business of A-S Medication Solutions (2019-2024)
Table 50. A-S Medication Solutions Recent Developments
Table 51. Taro Pharmaceuticals Basic Information List
Table 52. Taro Pharmaceuticals Description and Business Overview
Table 53. Taro Pharmaceuticals Adapalene Products, Services and Solutions
Table 54. Revenue (US$ Million) in Adapalene Business of Taro Pharmaceuticals (2019-2024)
Table 55. Taro Pharmaceuticals Recent Developments
Table 56. Sandoz Inc. Basic Information List
Table 57. Sandoz Inc. Description and Business Overview
Table 58. Sandoz Inc. Adapalene Products, Services and Solutions
Table 59. Revenue (US$ Million) in Adapalene Business of Sandoz Inc. (2019-2024)
Table 60. Sandoz Inc. Recent Developments
Table 61. Prasco Laboratories Basic Information List
Table 62. Prasco Laboratories Description and Business Overview
Table 63. Prasco Laboratories Adapalene Products, Services and Solutions
Table 64. Revenue (US$ Million) in Adapalene Business of Prasco Laboratories (2019-2024)
Table 65. Prasco Laboratories Recent Developments
Table 66. Actavis Pharma Company Basic Information List
Table 67. Actavis Pharma Company Description and Business Overview
Table 68. Actavis Pharma Company Adapalene Products, Services and Solutions
Table 69. Revenue (US$ Million) in Adapalene Business of Actavis Pharma Company (2019-2024)
Table 70. Actavis Pharma Company Recent Developments
Table 71. Perrigo Basic Information List
Table 72. Perrigo Description and Business Overview
Table 73. Perrigo Adapalene Products, Services and Solutions
Table 74. Revenue (US$ Million) in Adapalene Business of Perrigo (2019-2024)
Table 75. Perrigo Recent Developments
Table 76. Physicians Total Care Basic Information List
Table 77. Physicians Total Care Description and Business Overview
Table 78. Physicians Total Care Adapalene Products, Services and Solutions
Table 79. Revenue (US$ Million) in Adapalene Business of Physicians Total Care (2019-2024)
Table 80. Physicians Total Care Recent Developments
Table 81. DPT Laboratories Basic Information List
Table 82. DPT Laboratories Description and Business Overview
Table 83. DPT Laboratories Adapalene Products, Services and Solutions
Table 84. Revenue (US$ Million) in Adapalene Business of DPT Laboratories (2019-2024)
Table 85. DPT Laboratories Recent Developments
Table 86. Tianjin Jinyao Pharmaceutical Basic Information List
Table 87. Tianjin Jinyao Pharmaceutical Description and Business Overview
Table 88. Tianjin Jinyao Pharmaceutical Adapalene Products, Services and Solutions
Table 89. Revenue (US$ Million) in Adapalene Business of Tianjin Jinyao Pharmaceutical (2019-2024)
Table 90. Tianjin Jinyao Pharmaceutical Recent Developments
Table 91. Heilongjiang fuhe Pharmaceutical Group Basic Information List
Table 92. Heilongjiang fuhe Pharmaceutical Group Description and Business Overview
Table 93. Heilongjiang fuhe Pharmaceutical Group Adapalene Products, Services and Solutions
Table 94. Revenue (US$ Million) in Adapalene Business of Heilongjiang fuhe Pharmaceutical Group (2019-2024)
Table 95. Heilongjiang fuhe Pharmaceutical Group Recent Developments
Table 96. Sichuan Mingxin Pharmaceutical Basic Information List
Table 97. Sichuan Mingxin Pharmaceutical Description and Business Overview
Table 98. Sichuan Mingxin Pharmaceutical Adapalene Products, Services and Solutions
Table 99. Revenue (US$ Million) in Adapalene Business of Sichuan Mingxin Pharmaceutical (2019-2024)
Table 100. Sichuan Mingxin Pharmaceutical Recent Developments
Table 101. Hainan Quanxing Pharmaceutical Basic Information List
Table 102. Hainan Quanxing Pharmaceutical Description and Business Overview
Table 103. Hainan Quanxing Pharmaceutical Adapalene Products, Services and Solutions
Table 104. Revenue (US$ Million) in Adapalene Business of Hainan Quanxing Pharmaceutical (2019-2024)
Table 105. Hainan Quanxing Pharmaceutical Recent Developments
Table 106. Jiangsu Zhongdan Pharmaceutical Basic Information List
Table 107. Jiangsu Zhongdan Pharmaceutical Description and Business Overview
Table 108. Jiangsu Zhongdan Pharmaceutical Adapalene Products, Services and Solutions
Table 109. Revenue (US$ Million) in Adapalene Business of Jiangsu Zhongdan Pharmaceutical (2019-2024)
Table 110. Jiangsu Zhongdan Pharmaceutical Recent Developments
Table 111. Jiangsu Fubang Pharmaceutical Basic Information List
Table 112. Jiangsu Fubang Pharmaceutical Description and Business Overview
Table 113. Jiangsu Fubang Pharmaceutical Adapalene Products, Services and Solutions
Table 114. Revenue (US$ Million) in Adapalene Business of Jiangsu Fubang Pharmaceutical (2019-2024)
Table 115. Jiangsu Fubang Pharmaceutical Recent Developments
Table 116. Key Raw Materials Lists
Table 117. Raw Materials Key Suppliers Lists
Table 118. Adapalene Downstream Customers
Table 119. Adapalene Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 123. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Adapalene Product Picture
Figure 2. Global Adapalene Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Adapalene Sales Value (2019-2030) & (US$ Million)
Figure 4. Adapalene Report Years Considered
Figure 5. Global Adapalene Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Adapalene Revenue in 2023
Figure 7. Adapalene Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Cream Picture
Figure 9. Gel Picture
Figure 10. Lotion Picture
Figure 11. Global Adapalene Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Adapalene Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Hospital
Figure 14. Product Picture of Compounding Pharmacy
Figure 15. Product Picture of Skin Clinic
Figure 16. Product Picture of Beauty Center
Figure 17. Product Picture of Brick-and-mortar Pharmacy
Figure 18. Product Picture of Other
Figure 19. Global Adapalene Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Adapalene Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Adapalene Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Adapalene Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Adapalene Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Adapalene Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Adapalene Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Adapalene Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Adapalene Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Adapalene Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Adapalene Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Adapalene Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Adapalene Sales Value (%), (2019-2030)
Figure 32. United States Adapalene Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Adapalene Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Adapalene Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Adapalene Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Adapalene Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Adapalene Sales Value by Application (%), 2023 VS 2030
Figure 38. China Adapalene Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Adapalene Sales Value by Type (%), 2023 VS 2030
Figure 40. China Adapalene Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Adapalene Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Adapalene Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Adapalene Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Adapalene Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Adapalene Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Adapalene Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Adapalene Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Adapalene Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Adapalene Sales Value by Application (%), 2023 VS 2030
Figure 50. India Adapalene Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Adapalene Sales Value by Type (%), 2023 VS 2030
Figure 52. India Adapalene Sales Value by Application (%), 2023 VS 2030
Figure 53. Adapalene Industrial Chain
Figure 54. Adapalene Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Description
Adapalene is a third generation retinoid used primarily to treat mild to moderate acne, but is also used to treat Keratosis Pilaris and other skin conditions. The global market for Adapalene was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Adapalene was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Adapalene was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Adapalene was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Adapalene include Galderma, Glenmark Pharmaceuticals, Fougera Pharmaceuticals, A-S Medication Solutions, Taro Pharmaceuticals, Sandoz Inc., Prasco Laboratories, Actavis Pharma Company and Perrigo, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Adapalene, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Adapalene by region & country, by Type, and by Application.
The Adapalene market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adapalene.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Adapalene manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Adapalene in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Adapalene in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
Add to Cart
Buy Now